The Profit Motive Behind New Alzheimer’s Treatments (opens in new tab)

Big Pharma and industry-funded advocacy groups are promoting Alzheimer’s blood testing that could label millions of Americans as sick — despite dangerous treatments for early diagnoses of the disease.